News & Blog

Biases in brief cognitive tests revealed

28th November 2018

Quick tests used in primary care settings to identify whether people are likely to have dementia may often be wrong, according to a study published in the November 28, 2018, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology.   The tests, called brief cognitive assessments, evaluate thinking and […]


Landmark Futures 2019 Award

21st November 2018

Our team have received a Landmark Futures Award from the Landmark Trust. Only 20% of applicants were lucky enough to benefit from this prestigious scheme, which provides research groups with protected time to get away from it all in beautiful surroundings. We will be staying at Wortham Manor near Lifton in Devon, a medieval and […]


Turing Fellowship to advance AI use in dementia identification

10th October 2018

Dr David Llewellyn has been awarded the prestigious Turing Fellowship which will aim to accelerate the application of machine learning within the healthcare industry. Dr Llewellyn will use the Fellowship to fund research into the potential of machine learning to promote new treatments and interventions, and the timely identification of dementia. In addition to identifying […]


Stroke doubles dementia risk

31st August 2018

The University of Exeter Medical School led a study which analysed data on stroke and dementia risk from 3.2 million people across the world. The link between stroke and dementia persisted even after taking into account other dementia risk factors such as blood pressure, diabetes and cardiovascular disease. Their findings give the strongest evidence to […]


Artificial Intelligence and Dementia: Q&A

20th August 2018

Artificial Intelligence (AI) – human intelligence exhibited by machines – in healthcare is developing rapidly, with many applications currently in use or in development in the UK and worldwide. We speak to Dr David Llewellyn, a Senior Research Fellow in Clinical Epidemiology at the University of Exeter Medical School, about the impact of AI on dementia diagnosis. […]


Epic bike ride raises thousands

31st July 2018

Two researchers at the University of Exeter have pedalled a whopping 460 km from London to Paris, raising thousands of pounds for Alzheimer’s Society in a gruelling four-day challenge. Drs Mark Tarrant and David Llewellyn have exceeded their £1,550 fundraising target for the Society, raising over £2,000 so far to boost the Society’s ground-breaking dementia […]


Deprivation increases dementia risk

16th May 2018

Older adults in England with fewer financial resources are more likely to develop dementia, according to new UCL and University of Exeter research. Researchers analysed data from over 6,000 adults born between 1902 and 1943 and found that the 20% most deprived adults were 50% more likely to develop dementia than the 20% least deprived […]


HCAP study fieldwork complete

2nd May 2018

The Healthy Cognitive Aging Project (HCAP) is a sub-study carried out within the English Longitudinal Study of Ageing (ELSA). The project aims to investigate dementia risk using a harmonised cognitive assessment protocol, as part of an international research collaboration supported by a $2.4 million grant from the US National Institute on Aging (NIA). The study incorporates 1,300 men and […]


Impact of DECODE system on memory clinics

29th March 2018

Background A large proportion of people who are referred to memory clinics are cognitively healthy and do not receive a diagnosis of dementia or another cognitive deficit. This places unnecessary strain on stretched services locally, nationally and internationally. A team at the University of Exeter led by Dr David Llewellyn, have developed a clinical decision […]


DECODE system Highly Commended by AXA Healthcare

7th March 2018

The DECODE system has been Highly Commended by AXA Healthcare in their Heroes of Health Tech award for Innovations in the Early Diagnosis of Dementia. In partnership with Alzheimer’s Research UK, this award aims to identify excellence in design innovation and technology development that can support the diagnosis of diseases underpinning dementia. The panel were […]